CDKN2A and brain stem glioma: We reasoned that if loss of p53 transactivation domain function is the determinant of radiosensitization by Atm loss, then brainstem gliomas with both Ink4A and ARF loss and expression of a transactivation-deficient p5325,26 allele would be radiosensitized by Atm loss.